8 employees
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
2021
$13M
from 3 investors over 3 rounds
Shennon Biotechnologies raised $13M on March 13, 2023
Investors: Foundation Capital, Data Collective and AV8 Ventures